marketcaparena

TLPH

TALPHERA, INC.

Company overview

Market capitalization
$61.77M
Employees
12
Latest publication
2026-09-29
About TALPHERA, INC.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue0USD0USD0USD1,000USD0USD27,000USD6,684,000USD0USD
Cost Of Revenue0USD————1,169,000USD1,323,000USD2,053,000USD
Gross Profit0USD——1,000USD—-1,142,000USD-1,323,000USD-2,053,000USD
Research Development1,690,000USD1,650,000USD1,561,000USD1,803,000USD1,500,000USD1,169,000USD1,323,000USD2,053,000USD
Selling General Administrative2,234,000USD2,298,000USD1,892,000USD1,620,000USD2,193,000USD1,774,000USD1,673,000USD1,696,000USD
Total Operating Expenses3,924,000USD3,948,000USD3,453,000USD3,423,000USD3,693,000USD1,774,000USD1,673,000USD1,696,000USD
Operating Income-3,924,000USD-3,948,000USD-3,453,000USD-3,422,000USD-3,693,000USD-2,916,000USD-2,996,000USD-3,749,000USD
Total Other Income Expense Net-388,000USD1,392,000USD-319,000USD-1,014,000USD204,000USD250,000USD1,126,000USD396,000USD
Discontinued Operations0USD———————
Net Income-4,312,000USD-2,556,000USD-3,772,000USD-4,436,000USD-3,489,000USD-2,593,000USD-1,870,000USD-3,353,000USD
Interest Income—169,000USD203,000USD81,000USD83,000USD69,000USD103,000USD155,000USD
Net Interest Income—169,000USD203,000USD81,000USD83,000USD69,000USD103,000USD155,000USD
Income Before Tax—-2,556,000USD-3,772,000USD-4,436,000USD-3,489,000USD-2,666,000USD-1,870,000USD-3,353,000USD
Net Income From Continuing Ops—-2,556,000USD-3,772,000USD-4,436,000USD-3,489,000USD-2,666,000USD-1,870,000USD-3,353,000USD
Ebitda—-3,948,000USD-3,772,000USD-4,436,000USD-3,489,000USD-2,666,000USD-2,972,000USD-3,725,000USD
Interest Expense——0USD0USD0USD0USD788,000USD0USD
Unclassified Operating Expenses—————-1,169,000USD-1,323,000USD-2,053,000USD
Depreciation And Amortization—————2,916,000USD24,000USD24,000USD
Income Tax Expense——————24,000USD—
Ebit——————-2,996,000USD-3,749,000USD
Reconciled Depreciation——————0USD0USD
Tax Provision———————0USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue28,000USD0USD651,000USD1,771,000USD378,000USD5,416,000USD2,289,000USD2,151,000USD
Gross Profit28,000USD-6,718,000USD-4,895,000USD-1,647,000USD-2,628,000USD-616,000USD-4,517,000USD-1,825,000USD
Research Development6,033,000USD6,718,000USD5,546,000USD1,694,000USD2,435,000USD4,017,000USD4,661,000USD13,137,000USD
Selling General Administrative7,479,000USD8,534,000USD11,994,000USD17,011,000USD30,935,000USD36,330,000USD43,927,000USD20,265,000USD
Total Operating Expenses13,512,000USD8,534,000USD11,994,000USD18,705,000USD15,488,000USD40,347,000USD49,688,000USD33,902,000USD
Operating Income-13,484,000USD-15,252,000USD-16,889,000USD-20,352,000USD-18,116,000USD-40,963,000USD-54,205,000USD-35,727,000USD
Interest Income436,000USD679,000USD6,736,000USD1,502,000USD3,162,000USD3,893,000USD——
Interest Expense0USD394,000USD134,000USD1,116,000USD2,291,000USD3,305,000USD2,535,000USD12,558,000USD
Net Interest Income436,000USD285,000USD6,602,000USD386,000USD871,000USD588,000USD——
Income Before Tax-14,363,000USD-13,004,000USD-10,287,001USD59,138,000USD-17,147,000USD-40,375,000USD-53,237,000USD-47,147,000USD
Net Income-14,290,000USD-13,004,000USD-18,397,000USD42,515,000USD-35,099,000USD-40,379,000USD-53,240,000USD-47,149,000USD
Net Income From Continuing Ops-14,363,000USD-13,004,000USD-10,287,000USD59,125,000USD-35,099,000USD-40,379,000USD——
Ebitda-14,363,000USD-15,156,000USD-16,793,000USD61,901,000USD-16,143,000USD-35,217,000USD-49,034,000USD-34,014,000USD
Total Other Income Expense Net-879,000USD2,248,000USD6,601,999USD79,490,000USD969,000USD588,000USD968,000USD-11,420,000USD
Cost Of Revenue—6,718,000USD5,546,000USD1,647,000USD3,006,000USD6,032,000USD6,806,000USD3,976,000USD
Unclassified Operating Expenses—-6,718,000USD-5,546,000USD—-17,882,000USD———
Ebit—-15,252,000USD-16,889,000USD60,254,000USD-18,116,000USD-37,070,000USD-50,702,000USD-34,589,000USD
Depreciation And Amortization—96,000USD96,000USD1,647,000USD1,973,000USD1,853,000USD1,668,000USD575,000USD
Reconciled Depreciation—0USD311,000USD1,647,000USD1,973,000USD1,853,000USD——
Income Tax Expense——14,846,000USD13,000USD5,000USD4,000USD3,000USD2,000USD
Tax Provision——0USD13,000USD5,000USD4,000USD——
Selling And Marketing Expenses——————1,100,000USD500,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets26,806,000USD30,155,000USD29,719,000USD30,742,000USD16,515,000USD14,995,000USD18,236,000USD21,014,000USD
Cash And Equivalents742,000USD———————
Cash And Short Term Investments17,076,000USD21,108,000USD20,381,000USD21,289,000USD6,791,000USD5,388,000USD8,863,000USD11,117,000USD
Short Term Investments16,334,000USD17,285,000USD14,487,000USD17,832,000USD——0USD0USD
Total Current Assets17,987,000USD21,336,000USD20,900,000USD21,923,000USD7,696,000USD6,176,000USD9,417,000USD12,195,000USD
Other Current Assets911,000USD228,000USD519,000USD634,000USD905,000USD788,000USD554,000USD1,078,000USD
Total Liabilities12,400,000USD———————
Total Current Liabilities4,188,000USD4,025,000USD3,809,000USD3,212,000USD2,630,000USD1,989,000USD2,647,000USD2,762,000USD
Other Current Liabilities3,151,000USD———————
Total Stockholder Equity14,406,000USD18,478,000USD17,035,000USD19,177,000USD6,627,000USD5,599,000USD8,000,999USD9,641,000USD
Total Equity Including Noncontrolling Interest14,406,000USD———————
Intangible Assets8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD
Accounts Payable387,000USD927,000USD544,000USD526,000USD835,000USD326,000USD670,000USD396,000USD
Common Stock52,000USD50,000USD49,000USD46,000USD20,000USD17,000USD17,000USD17,000USD
Retained Earnings-478,388,000USD-474,076,000USD-471,520,000USD-467,748,000USD-463,312,000USD-459,823,000USD-457,230,000USD-455,360,000USD
Total Liab—11,677,000USD12,684,000USD11,565,000USD9,888,000USD9,396,000USD10,235,001USD11,373,000USD
Other Current Liab—3,098,000USD3,265,000USD2,686,000USD1,795,000USD1,663,000USD1,977,000USD2,366,000USD
Capital Stock—50,000USD49,000USD46,000USD20,000USD17,000USD17,000USD17,000USD
Cash—3,823,000USD5,894,000USD3,457,000USD6,791,000USD5,388,000USD8,863,000USD11,117,000USD
Net Debt—-3,823,000USD605,000USD3,042,000USD-6,791,000USD-5,388,000USD-2,336,000USD-4,590,000USD
Common Stock Shares Outstanding—42,410,711shares42,410,711shares41,453,382shares34,530,377shares26,268,209shares26,238,000shares26,212,902shares
Non Current Assets Total—8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD8,819,000USD
Non Current Liabilities Total—7,652,000USD8,875,000USD8,353,000USD7,258,000USD7,407,000USD7,588,001USD8,611,000USD
Non Current Liabilities Other—6,499,000USD6,499,000USD6,499,000USD6,499,000USD6,527,000USD6,527,000USD6,527,000USD
Non Currrent Assets Other—8,819,000USD8,819,000USD8,819,000USD—8,819,000USD8,819,000USD8,818,999USD
Net Working Capital—17,311,000USD17,091,000USD18,711,000USD5,066,000USD4,187,000USD6,770,000USD9,433,000USD
Unclassified Non Current Assets—-8,819,000USD-8,819,000USD-8,819,000USD—-8,819,000USD-8,819,000USD-8,818,999USD
Unclassified Non Current Liabilities—1,153,000USD2,376,000USD1,854,000USD——1,061,001USD2,084,000USD
Unclassified Equity—492,454,000USD488,457,000USD486,833,000USD469,899,000USD465,388,000USD465,196,999USD464,967,000USD
Short Long Term Debt Total——6,499,000USD6,499,000USD6,499,000USD6,527,000USD6,527,000USD6,527,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets29,719,000USD18,236,000USD20,395,000USD47,487,000USD77,893,000USD66,295,000USD91,356,000USD120,533,000USD
Intangible Assets8,819,000USD8,819,000USD8,819,000USD8,819,000USD————
Other Current Assets519,000USD554,000USD2,175,000USD7,309,000USD2,588,000USD1,683,000USD1,824,000USD1,024,000USD
Total Liab12,684,000USD10,235,001USD6,290,000USD25,673,000USD113,786,000USD122,045,000USD132,774,000USD116,280,000USD
Total Stockholder Equity17,035,000USD8,000,999USD14,105,000USD21,814,000USD-35,893,000USD-55,750,000USD-41,418,000USD4,253,000USD
Other Current Liab3,265,000USD1,977,000USD3,176,000USD5,335,000USD6,438,000USD5,045,000USD5,939,000USD4,540,000USD
Common Stock49,000USD17,000USD17,000USD8,000USD7,000USD98,000USD79,000USD78,000USD
Capital Stock49,000USD17,000USD17,000USD8,000USD7,000USD98,000USD——
Retained Earnings-471,520,000USD-457,230,000USD-444,226,000USD-425,829,000USD-473,584,000USD-438,485,000USD-398,106,000USD-345,019,000USD
Cash5,894,000USD8,863,000USD5,721,000USD15,275,000USD7,663,000USD27,274,000USD14,684,000USD87,975,000USD
Cash And Short Term Investments20,381,000USD8,863,000USD9,381,000USD15,770,000USD46,630,000USD42,886,000USD66,137,000USD105,715,000USD
Total Current Assets20,900,000USD9,417,000USD11,556,000USD24,566,000USD50,489,000USD46,830,000USD71,688,000USD107,994,000USD
Total Current Liabilities3,809,000USD2,647,000USD4,512,000USD13,770,000USD18,509,000USD17,635,000USD13,611,000USD15,928,000USD
Net Debt605,000USD-2,336,000USD-5,721,000USD-5,252,000USD10,958,000USD-1,675,000USD107,108,000USD17,695,000USD
Short Long Term Debt Total6,499,000USD6,527,000USD—10,023,000USD18,621,000USD25,599,000USD121,792,000USD105,670,000USD
Short Term Investments14,487,000USD0USD3,660,000USD495,000USD38,967,000USD15,612,000USD51,453,000USD17,740,000USD
Accounts Payable544,000USD670,000USD1,336,000USD1,256,000USD2,121,000USD2,737,000USD1,720,000USD2,070,000USD
Common Stock Shares Outstanding42,410,711shares25,845,639shares14,263,744shares7,406,986shares5,993,013shares4,262,850shares3,959,213shares2,920,427shares
Non Current Assets Total8,819,000USD8,819,000USD8,839,000USD22,921,000USD27,404,000USD19,465,000USD19,668,000USD12,539,000USD
Non Current Liabilities Total8,875,000USD7,588,001USD1,778,000USD11,903,000USD95,277,000USD104,410,000USD119,163,000USD100,352,000USD
Non Current Liabilities Other6,499,000USD6,527,000USD—810,000USD85,369,000USD88,664,000USD92,173,000USD—
Non Currrent Assets Other8,819,000USD8,819,000USD20,000USD246,000USD7,174,000USD656,000USD1,188,000USD527,000USD
Net Working Capital17,091,000USD6,770,000USD7,044,000USD10,796,000USD31,980,000USD29,195,000USD——
Unclassified Non Current Assets-8,819,000USD-8,819,000USD——————
Unclassified Non Current Liabilities2,376,000USD1,061,001USD1,778,000USD11,093,000USD4,901,000USD2,606,000USD6,473,000USD100,352,000USD
Unclassified Equity488,457,000USD465,196,999USD458,297,000USD447,627,000USD437,677,000USD382,539,000USD356,609,000USD349,194,000USD
Current Deferred Revenue———115,000USD86,000USD49,000USD411,000USD315,000USD
Short Term Debt———7,064,000USD9,864,000USD9,853,000USD5,952,000USD11,685,000USD
Short Long Term Debt———5,363,000USD8,796,000USD8,735,000USD4,630,000USD—
Net Receivables———309,000USD160,000USD635,000USD432,000USD401,000USD
Inventory———1,178,000USD1,111,000USD1,626,000USD3,295,000USD854,000USD
Property Plant Equipment Net———13,856,000USD20,230,000USD18,809,000USD18,480,000USD11,483,000USD
Property Plant Equipment Gross———25,449,000USD31,016,000USD29,398,000USD28,032,000USD—
Unclassified Current Liabilities———-5,363,000USD-8,796,000USD-8,784,000USD-5,041,000USD-2,682,000USD
Long Term Debt————5,007,000USD13,140,000USD20,517,000USD—
Other Assets——————1USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-2,556,000USD-3,845,000USD-4,436,000USD-3,489,000USD-2,666,000USD-1,870,000USD-3,353,000USD-3,827,000USD
Depreciation-84,000USD-125,000USD-17,000USD——0USD-121,000USD0USD
Stock Based Compensation214,000USD185,000USD152,000USD166,000USD196,000USD230,000USD234,000USD223,000USD
Other Non Cash Items-1,093,000USD595,000USD1,077,000USD-148,000USD-108,000USD-1,023,000USD-120,000USD-291,000USD
Change To Account Receivables0USD——27,000USD-27,000USD———
Change In Working Capital249,000USD754,000USD697,000USD523,000USD-892,000USD409,000USD424,000USD-715,000USD
Total Cash From Operating Activities-3,400,000USD-2,436,000USD-2,510,000USD-2,948,000USD-3,470,000USD-2,254,000USD-2,936,000USD-4,610,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
Free Cash Flow-3,400,000USD-2,436,000USD-2,510,000USD-2,948,000USD-3,470,000USD-2,254,000USD-2,936,000USD-4,610,000USD
Investments-2,714,000USD3,470,000USD-17,815,000USD0USD0USD0USD600,000USD5,911,000USD
Total Cashflows From Investing Activities-2,714,000USD3,470,000USD-17,815,000USD———600,000USD5,911,000USD
Total Cash From Financing Activities4,043,000USD1,403,000USD16,991,000USD4,351,000USD-5,000USD0USD30,000USD0USD
Issuance Of Capital Stock4,038,000USD———0USD0USD——
Change In Cash-2,071,000USD2,437,000USD-3,334,000USD1,403,000USD-3,475,000USD-2,254,000USD-2,306,000USD1,301,000USD
Begin Period Cash Flow5,894,000USD3,457,000USD6,791,000USD5,388,000USD8,863,000USD11,117,000USD13,423,000USD12,122,000USD
End Period Cash Flow3,823,000USD5,894,000USD3,457,000USD6,791,000USD5,388,000USD8,863,000USD11,117,000USD13,423,000USD
Other Cashflows From Financing Activities4,043,000USD1,403,000USD16,991,000USD—-27,000USD5,884,000USD30,000USD5,911,000USD
Unclassified Financing Cash Flow-4,038,000USD——4,354,000USD———-5,911,000USD
Sale Purchase Of Stock—-3,000USD8,000USD-3,000USD—-5,884,000USD3,000USD—
Other Cashflows From Investing Activities————2,730,000USD2,730,000USD——
Change To Inventory—————0USD0USD0USD
Net Borrowings—————0USD0USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-14,290,000USD-13,004,000USD-18,397,000USD47,755,000USD-35,099,000USD-40,379,000USD-53,240,000USD-47,149,000USD
Depreciation-142,000USD-121,000USD311,000USD1,647,000USD1,973,000USD1,853,000USD1,668,000USD575,000USD
Stock Based Compensation699,000USD989,000USD1,729,000USD2,889,000USD4,609,000USD4,424,000USD5,057,000USD5,168,000USD
Other Non Cash Items1,287,000USD-323,000USD-1,792,000USD-79,232,000USD-2,498,000USD-2,827,000USD11,076,000USD14,738,000USD
Change In Working Capital1,082,000USD-224,000USD-1,541,000USD-1,390,000USD203,000USD-2,288,000USD-3,906,000USD1,867,000USD
Total Cash From Operating Activities-11,364,000USD-12,683,000USD-17,492,000USD-28,331,000USD-30,002,000USD-38,505,000USD-51,180,000USD-29,075,000USD
Capital Expenditures0USD0USD-100,000USD-364,000USD-1,827,000USD-1,855,000USD-3,470,000USD-819,000USD
Free Cash Flow-11,364,000USD-12,683,000USD-17,592,000USD-28,695,000USD-31,829,000USD-40,360,000USD-54,650,000USD-29,894,000USD
Investments-14,345,000USD3,781,000USD-528,000USD36,450,000USD-26,123,000USD34,139,000USD——
Total Cashflows From Investing Activities-14,345,000USD3,781,000USD-528,000USD36,450,000USD-26,123,000USD34,139,000USD-36,563,000USD-10,877,000USD
Total Cash From Financing Activities22,740,000USD12,044,000USD3,466,000USD-507,000USD41,514,000USD16,956,000USD14,452,000USD75,025,000USD
Change In Cash-2,969,000USD3,142,000USD-14,554,000USD7,612,000USD-14,611,000USD12,590,000USD-73,291,000USD35,073,000USD
Begin Period Cash Flow8,863,000USD5,721,000USD20,275,000USD12,663,000USD27,274,000USD14,684,000USD87,975,000USD52,902,000USD
End Period Cash Flow5,894,000USD8,863,000USD5,721,000USD20,275,000USD12,663,000USD27,274,000USD14,684,000USD87,975,000USD
Other Cashflows From Financing Activities22,740,000USD12,044,000USD26,000USD-60,000USD69,000USD286,000USD553,000USD1,218,000USD
Change To Inventory—0USD61,000USD-107,000USD-295,000USD957,000USD-3,392,000USD102,000USD
Net Borrowings—0USD-5,416,000USD-8,433,000USD-8,833,000USD———
Issuance Of Capital Stock—0USD8,856,000USD8,225,000USD50,278,000USD21,337,000USD——
Change To Account Receivables——-189,000USD-149,000USD475,000USD-203,000USD-31,000USD1,484,000USD
Sale Purchase Of Stock——-22,000USD-315,000USD-249,000USD-86,000USD——
Other Cashflows From Investing Activities——2,723,000USD-1,687,000USD-821,000USD35,994,000USD-33,093,000USD-10,058,000USD
Unclassified Operating Cash Flow——2,198,000USD———-11,835,000USD-4,274,000USD
Unclassified Investing Cash Flow——-2,623,000USD2,051,000USD2,648,000USD-34,139,000USD——
Unclassified Financing Cash Flow——8,878,000USD8,301,000USD50,527,000USD16,756,000USD13,899,000USD73,807,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
FY 2022Yearly · 2022-12-31ProductContract And Other Collaboration0USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductContract And Other Revenue0USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductDSUVIA1,588,000USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductDZUVEO183,000USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductLicense0USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductNon Cash Royalty0USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductRoyalty0USD0001437749-23-008737
FY 2022Yearly · 2022-12-31ProductZALVISO0USD0001437749-23-008737
Q3 2022Quarterly · 2022-09-30ProductContract And Other Collaboration0USD0001437749-22-027307
Q3 2022Quarterly · 2022-09-30ProductDSUVIA478,000USD0001437749-22-027307
Q3 2022Quarterly · 2022-09-30ProductDZUVEO29,000USD0001437749-22-027307
Q2 2022Quarterly · 2022-06-30ProductContract And Other Collaboration0USD0001437749-22-020168
Q2 2022Quarterly · 2022-06-30ProductDSUVIA444,000USD0001437749-22-020168
Q2 2022Quarterly · 2022-06-30ProductDZUVEO126,000USD0001437749-22-020168
Q1 2022Quarterly · 2022-03-31ProductContract And Other Collaboration0USD0001437749-22-012491
Q1 2022Quarterly · 2022-03-31ProductDSUVIA442,000USD0001437749-22-012491
Q1 2022Quarterly · 2022-03-31ProductNon Cash Royalty0USD0001437749-22-012491
Q1 2022Quarterly · 2022-03-31ProductRoyalty0USD0001437749-22-012491
Q1 2022Quarterly · 2022-03-31ProductZALVISO0USD0001437749-22-012491
FY 2021Yearly · 2021-12-31ProductContract And Other Collaboration — License1,696,000USD0001437749-23-008737
FY 2021Yearly · 2021-12-31ProductContract And Other Collaboration — Non Cash Royalty83,000USD0001437749-23-008737
FY 2021Yearly · 2021-12-31ProductContract And Other Collaboration — Royalty28,000USD0001437749-23-008737
FY 2021Yearly · 2021-12-31ProductContract And Other Revenue6,000USD0001437749-23-008737
FY 2021Yearly · 2021-12-31ProductDSUVIA735,000USD0001437749-23-008737
FY 2021Yearly · 2021-12-31ProductDZUVEO0USD0001437749-23-008737
FY 2021Yearly · 2021-12-31ProductZALVISO270,000USD0001437749-23-008737
Q3 2021Quarterly · 2021-09-30ProductContract And Other Collaboration — License1,696,000USD0001437749-22-027307
Q3 2021Quarterly · 2021-09-30ProductContract And Other Revenue166,000USD0001437749-22-027307
Q3 2021Quarterly · 2021-09-30ProductNon Cash Royalty0USD0001437749-22-027307
Q3 2021Quarterly · 2021-09-30ProductRoyalty0USD0001437749-22-027307
Q3 2021Quarterly · 2021-09-30ProductZALVISO0USD0001437749-22-027307
Q1 2021Quarterly · 2021-03-31ProductContract And Other Collaboration — Non Cash Royalty45,000USD0001437749-22-012491
Q1 2021Quarterly · 2021-03-31ProductContract And Other Collaboration — Royalty15,000USD0001437749-22-012491
Q1 2021Quarterly · 2021-03-31ProductDSUVIA181,000USD0001437749-22-012491
Q1 2021Quarterly · 2021-03-31ProductZALVISO270,000USD0001437749-22-012491
FY 2020Yearly · 2020-12-31ProductContract And Other Collaboration — Non Cash Royalty242,000USD0001437749-22-005888
FY 2020Yearly · 2020-12-31ProductContract And Other Collaboration — Royalty81,000USD0001437749-22-005888
FY 2020Yearly · 2020-12-31ProductContract And Other Revenue2,572,000USD0001437749-22-005888
FY 2020Yearly · 2020-12-31ProductDSUVIA1,409,000USD0001437749-22-005888
FY 2020Yearly · 2020-12-31ProductLicense0USD0001437749-22-005888
FY 2020Yearly · 2020-12-31ProductZALVISO1,112,000USD0001437749-22-005888
Q2 2020Quarterly · 2020-06-30ProductAmended License Agreement — Contract And Other Revenue2,572,000USD0001437749-21-020165
Q2 2020Quarterly · 2020-06-30ProductAmended License Agreement — ZALVISO301,000USD0001437749-21-020165
Q2 2020Quarterly · 2020-06-30ProductContract And Other Collaboration — Non Cash Royalty37,000USD0001437749-21-020165
Q2 2020Quarterly · 2020-06-30ProductContract And Other Collaboration — Royalty12,000USD0001437749-21-020165
Q2 2020Quarterly · 2020-06-30ProductDSUVIA2,000USD0001437749-21-020165
FY 2019Yearly · 2019-12-31ProductAmended License Agreement — Contract And Other Revenue43,000USD0001437749-21-006074
FY 2019Yearly · 2019-12-31ProductAmended License Agreement — ZALVISO1,453,000USD0001437749-21-006074
FY 2019Yearly · 2019-12-31ProductContract And Other Collaboration — Non Cash Royalty312,000USD0001437749-21-006074
FY 2019Yearly · 2019-12-31ProductContract And Other Collaboration — Royalty104,000USD0001437749-21-006074
FY 2019Yearly · 2019-12-31ProductDepartment Of Defense0USD0001437749-21-006074
FY 2019Yearly · 2019-12-31ProductDsuvia377,000USD0001437749-21-006074
Q3 2019Quarterly · 2019-09-30ProductAmended License Agreement — Contract And Other Revenue1,000USD0001437749-20-022799
Q3 2019Quarterly · 2019-09-30ProductAmended License Agreement — ZALVISO443,000USD0001437749-20-022799
Q3 2019Quarterly · 2019-09-30ProductContract And Other Collaboration — Non Cash Royalty36,000USD0001437749-20-022799
Q3 2019Quarterly · 2019-09-30ProductContract And Other Collaboration — Royalty12,000USD0001437749-20-022799
Q3 2019Quarterly · 2019-09-30ProductDsuvia116,000USD0001437749-20-022799
Q2 2019Quarterly · 2019-06-30ProductAmended License Agreement — Contract And Other Revenue70,000USD0001437749-20-017343
Q2 2019Quarterly · 2019-06-30ProductAmended License Agreement — ZALVISO713,000USD0001437749-20-017343
Q2 2019Quarterly · 2019-06-30ProductDsuvia — Royalty40,000USD0001437749-20-017343
Q2 2019Quarterly · 2019-06-30ProductNon Cash Royalty118,000USD0001437749-20-017343
FY 2017Yearly · 2017-12-31ProductCollaboration Agreement Revenue7,143,000USD0001437749-19-004353
FY 2017Yearly · 2017-12-31ProductContract And Other852,000USD0001437749-19-004353
FY 2016Yearly · 2016-12-31ProductCollaboration Agreement Revenue6,440,000USD0001437749-19-004353
FY 2016Yearly · 2016-12-31ProductContract And Other10,917,000USD0001437749-19-004353

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.